Collaborative Research: Chimeric Antigen Receptor Engineered Neutrophil Extracellular Vesi — NSF Award to Florida State University
CAR T-cells exhibit some success in the treatment of some cancer types. The acronym CAR refers the fact that the T-cell has been engineered to express a novel receptor protein on its surface. This receptor protein allows the cell to recognize tumor cells and activate the T-cell to attack it. Neutrophils are another typ
| Award title | Collaborative Research: Chimeric Antigen Receptor Engineered Neutrophil Extracellular Vesi |
|---|---|
| Award ID | 2425703 |
| Awardee | Florida State University |
| City | TALLAHASSEE |
| State | FL |
| Amount obligated | $350,000 |
| Principal investigator | Yan Li |
| Program | Cellular & Biochem Engineering |
| Start date | 09/01/2025 |
| Abstract | CAR T-cells exhibit some success in the treatment of some cancer types. The acronym CAR refers the fact that the T-cell has been engineered to express a novel receptor protein on its surface. This receptor protein allows the cell to recognize tumor cells and activate the T-cell to attack it. Neutrophils are another type of immune cell that may possess enhanced targeting to glioblastoma. Neutrophils also produce extracellular vesicles (EVs). EVs are membrane-enclosed particles that can carry some |
| Source | NSF Awards |
$799/mo
Try NSFGrants →